Logo image of CFX.CA

CANFOR PULP PRODUCTS INC (CFX.CA) Stock Fundamental Analysis

TSX:CFX - Toronto Stock Exchange - CA1375842079 - Common Stock - Currency: CAD

0.59  -0.04 (-6.35%)

Fundamental Rating

3

Overall CFX gets a fundamental rating of 3 out of 10. We evaluated CFX against 12 industry peers in the Paper & Forest Products industry. Both the profitability and financial health of CFX have multiple concerns. CFX has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CFX has reported negative net income.
In the past year CFX had a positive cash flow from operations.
In the past 5 years CFX always reported negative net income.
In the past 5 years CFX always reported a positive cash flow from operatings.
CFX.CA Yearly Net Income VS EBIT VS OCF VS FCFCFX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

Looking at the Return On Assets, with a value of -35.19%, CFX is doing worse than 91.67% of the companies in the same industry.
CFX's Return On Equity of -84.67% is on the low side compared to the rest of the industry. CFX is outperformed by 91.67% of its industry peers.
With an excellent Return On Invested Capital value of 4.00%, CFX belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
Industry RankSector Rank
ROA -35.19%
ROE -84.67%
ROIC 4%
ROA(3y)-20.14%
ROA(5y)-13.63%
ROE(3y)-46.33%
ROE(5y)-30.44%
ROIC(3y)N/A
ROIC(5y)N/A
CFX.CA Yearly ROA, ROE, ROICCFX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1.3 Margins

The Operating Margin of CFX (2.19%) is better than 66.67% of its industry peers.
CFX has a Gross Margin of 23.57%. This is in the better half of the industry: CFX outperforms 66.67% of its industry peers.
In the last couple of years the Gross Margin of CFX has remained more or less at the same level.
Industry RankSector Rank
OM 2.19%
PM (TTM) N/A
GM 23.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.78%
GM growth 5Y-0.73%
CFX.CA Yearly Profit, Operating, Gross MarginsCFX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 30

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CFX is destroying value.
The number of shares outstanding for CFX remains at a similar level compared to 1 year ago.
Compared to 5 years ago, CFX has about the same amount of shares outstanding.
Compared to 1 year ago, CFX has a worse debt to assets ratio.
CFX.CA Yearly Shares OutstandingCFX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CFX.CA Yearly Total Debt VS Total AssetsCFX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 1.04, we must say that CFX is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CFX (1.04) is worse than 83.33% of its industry peers.
The Debt to FCF ratio of CFX is 4.17, which is a neutral value as it means it would take CFX, 4.17 years of fcf income to pay off all of its debts.
CFX has a better Debt to FCF ratio (4.17) than 75.00% of its industry peers.
CFX has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
CFX's Debt to Equity ratio of 0.42 is in line compared to the rest of the industry. CFX outperforms 50.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 4.17
Altman-Z 1.04
ROIC/WACC0.41
WACC9.67%
CFX.CA Yearly LT Debt VS Equity VS FCFCFX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

CFX has a Current Ratio of 1.00. This is a normal value and indicates that CFX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.00, CFX is doing worse than 91.67% of the companies in the same industry.
A Quick Ratio of 0.26 indicates that CFX may have some problems paying its short term obligations.
The Quick ratio of CFX (0.26) is worse than 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 0.26
CFX.CA Yearly Current Assets VS Current LiabilitesCFX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

3

3. Growth

3.1 Past

CFX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 100.00%, which is quite impressive.
The Revenue has decreased by -9.60% in the past year.
Measured over the past years, CFX shows a decrease in Revenue. The Revenue has been decreasing by -6.00% on average per year.
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%325%
Revenue 1Y (TTM)-9.6%
Revenue growth 3Y-11.31%
Revenue growth 5Y-6%
Sales Q2Q%-11.74%

3.2 Future

Based on estimates for the next years, CFX will show a very strong growth in Earnings Per Share. The EPS will grow by 47.59% on average per year.
The Revenue is expected to decrease by -3.83% on average over the next years.
EPS Next Y309.77%
EPS Next 2Y102.43%
EPS Next 3Y4.63%
EPS Next 5Y47.59%
Revenue Next Year-14.15%
Revenue Next 2Y-7.74%
Revenue Next 3Y-3.83%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CFX.CA Yearly Revenue VS EstimatesCFX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
CFX.CA Yearly EPS VS EstimatesCFX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Forward Earnings ratio of 2.16, the valuation of CFX can be described as very cheap.
100.00% of the companies in the same industry are more expensive than CFX, based on the Price/Forward Earnings ratio.
CFX is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.04, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 2.16
CFX.CA Price Earnings VS Forward Price EarningsCFX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

CFX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CFX is cheaper than 100.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CFX indicates a rather cheap valuation: CFX is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.09
EV/EBITDA 0.57
CFX.CA Per share dataCFX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y102.43%
EPS Next 3Y4.63%

0

5. Dividend

5.1 Amount

No dividends for CFX!.
Industry RankSector Rank
Dividend Yield N/A

CANFOR PULP PRODUCTS INC

TSX:CFX (8/8/2025, 7:00:00 PM)

0.59

-0.04 (-6.35%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)07-31 2025-07-31
Earnings (Next)10-23 2025-10-23
Inst Owners19.91%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap38.49M
Analysts72.5
Price Target1.22 (106.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)62.28%
Min EPS beat(2)-13.76%
Max EPS beat(2)138.33%
EPS beat(4)3
Avg EPS beat(4)52.26%
Min EPS beat(4)-13.76%
Max EPS beat(4)138.33%
EPS beat(8)5
Avg EPS beat(8)36.75%
EPS beat(12)6
Avg EPS beat(12)-65.45%
EPS beat(16)8
Avg EPS beat(16)-78.84%
Revenue beat(2)1
Avg Revenue beat(2)-5.38%
Min Revenue beat(2)-15.23%
Max Revenue beat(2)4.48%
Revenue beat(4)3
Avg Revenue beat(4)-2.12%
Min Revenue beat(4)-15.23%
Max Revenue beat(4)4.48%
Revenue beat(8)5
Avg Revenue beat(8)-0.2%
Revenue beat(12)7
Avg Revenue beat(12)0.14%
Revenue beat(16)9
Avg Revenue beat(16)-0.06%
PT rev (1m)0%
PT rev (3m)-7.69%
EPS NQ rev (1m)-1001.2%
EPS NQ rev (3m)-128.95%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-3.64%
Revenue NQ rev (3m)-4.81%
Revenue NY rev (1m)-1.32%
Revenue NY rev (3m)-1.47%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.16
P/S 0.05
P/FCF 2.09
P/OCF 0.58
P/B 0.21
P/tB 0.21
EV/EBITDA 0.57
EPS(TTM)0
EYN/A
EPS(NY)0.27
Fwd EY46.22%
FCF(TTM)0.28
FCFY47.81%
OCF(TTM)1.01
OCFY172.01%
SpS11.84
BVpS2.78
TBVpS2.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -35.19%
ROE -84.67%
ROCE 7.37%
ROIC 4%
ROICexc 4.05%
ROICexgc 4.05%
OM 2.19%
PM (TTM) N/A
GM 23.57%
FCFM 2.38%
ROA(3y)-20.14%
ROA(5y)-13.63%
ROE(3y)-46.33%
ROE(5y)-30.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.78%
GM growth 5Y-0.73%
F-Score5
Asset Turnover1.77
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 4.17
Debt/EBITDA 1.1
Cap/Depr 91.22%
Cap/Sales 6.19%
Interest Coverage 1.48
Cash Conversion 95.53%
Profit Quality N/A
Current Ratio 1
Quick Ratio 0.26
Altman-Z 1.04
F-Score5
WACC9.67%
ROIC/WACC0.41
Cap/Depr(3y)90.9%
Cap/Depr(5y)90.41%
Cap/Sales(3y)7.88%
Cap/Sales(5y)7.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%325%
EPS Next Y309.77%
EPS Next 2Y102.43%
EPS Next 3Y4.63%
EPS Next 5Y47.59%
Revenue 1Y (TTM)-9.6%
Revenue growth 3Y-11.31%
Revenue growth 5Y-6%
Sales Q2Q%-11.74%
Revenue Next Year-14.15%
Revenue Next 2Y-7.74%
Revenue Next 3Y-3.83%
Revenue Next 5YN/A
EBIT growth 1Y114.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year140.96%
EBIT Next 3Y38.37%
EBIT Next 5Y25.98%
FCF growth 1Y210.84%
FCF growth 3Y-52.34%
FCF growth 5YN/A
OCF growth 1Y-26.12%
OCF growth 3Y-26.8%
OCF growth 5Y-0.34%